Er scores throughout. When statistically comparing the HER2 expression of primary
Er scores throughout. When statistically comparing the HER2 expression of primary tumor and metastases between therapeutic groups, a significantly higher HER2-expression was observed in the trastuzumab-treated group (p = 0.003)…